日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis

奥希替尼联合安罗替尼治疗获得性EGFR T790M突变的晚期非小细胞肺癌:一项多中心II期临床研究及ctDNA分析结果

Wang, Xinyue; Li, Zhaona; Wang, Liuchun; Liang, Yan; Huang, Chun; Chen, Peng; Huang, Dingzhi; Song, Xia; Ding, Cuimin; Wang, Changli; Jiang, Richeng

Microbiome-metabolome dysbiosis of bronchoalveolar lavage fluid of lung cancer patients

肺癌患者支气管肺泡灌洗液微生物组-代谢组失调

Wang, Jing; Su, Wei; Chen, Qin; Zhou, Jiemin; Wang, Xinyue; Jiang, Richeng; Li, Junling; Xing, Puyuan

PLCXD3-ALK, a novel ALK rearrangement in lung squamous cell carcinoma and its clinical responses to ALK inhibitors.

PLCXD3-ALK,肺鳞状细胞癌中的一种新型ALK重排及其对ALK抑制剂的临床反应

Chen Kaidi, Chen Xiuqiong, Wang Xinyue, Yan Bing, Liu Aiqin, Wang Youhui, Zhou Jing, Wei Qianhui, Pan Yi, Jiang Richeng

Exploring the protective association between COVID-19 infection and laryngeal cancer: insights from a Mendelian randomization study

探索 COVID-19 感染与喉癌之间的保护性关联:来自孟德尔随机化研究的启示

Wang, Heng; Fang, Ning; Mozumder, Prithweeraj; Jiang, Richeng; Wang, Xin

Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients

CT扫描中既往肺部磨玻璃影的定量分析可用于预测晚期非小细胞肺癌患者的免疫检查点抑制剂肺炎

Wang, Xinyue; Zhao, Jinkun; Mei, Ting; Liu, Wenting; Chen, Xiuqiong; Wang, Jingya; Jiang, Richeng; Ye, Zhaoxiang; Huang, Dingzhi

Characteristics of T Cells in Single-Cell Datasets of Peripheral Blood and Cerebrospinal Fluid in Alzheimer's Disease Patients

阿尔茨海默病患者外周血和脑脊液单细胞数据集中的T细胞特征

Wang, Yongchun; Jiang, Richeng; Li, Mingxi; Wang, Zicheng; Yang, Yu; Sun, Li

Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer

晚期非小细胞肺癌中免疫检查点抑制剂的再次应用

Lin, Gen; Wang, Zhijie; Chu, Qian; Hu, Yi; Huang, Dingzhi; Wang, Jun; Yang, Fan; Zhong, Wenzhao; Zhou, Chengzhi; Zhu, Bo; Ai, Xinghao; Cao, Baoshan; Cao, Yabing; Chen, Mingqiu; Chen, Xiaohui; Chu, Tianqing; Duan, Jianchun; Fan, Yun; Fang, Yong; Feng, Shuitu; Feng, Weineng; Guo, Hui; Han, Chengbo; He, Yong; Hong, Shaodong; Hu, Jie; Huang, Meijuan; Huang, Yan; Jiang, Da; Jiang, Kan; Jiang, Richeng; Jin, Bo; Jin, Shi; Li, Jisheng; Li, Min; Li, Ziming; Li, Chao; Lin, Jie; Liu, Anwen; Liu, Si-Yang Maggie; Yutao, Liu; Liu, Zhefeng; Liu, Zhe; Liu, Zhenhua; Liu, Zhentian; Liu, Zhigang; Lu, Yuping; Lv, Tangfeng; Ma, Zhiyong; Miao, Qian; Peng, Min; Pu, Xingxiang; Ren, Xiu Bao; Shan, Jianzhen; Shan, Jinlu; Shen, Peng; Shen, Bo; Shi, Meiqi; Song, Yong; Song, Zhengbo; Su, ChunXia; Sun, Jianguo; Tian, Panwen; Wang, Jinliang; Wang, Feng; Wang, Huijuan; Wang, Jialei; Wang, Qian; Wang, Wenxian; Wang, Yan; Wu, Lin; Wu, Fang; Xia, Yang; Xie, Congying; Xie, Conghua; Xin, Tao; Xiong, Jianping; Xu, Haipeng; Xu, Song; Xu, Yiquan; Xu, Bin; Xu, Chunwei; Yan, Xiaolong; Yang, Zhenzhou; Yao, Wenxiu; Yu, Yao; Feng, Ye; Yu, Zongyang; Yu, Yongfeng; Yue, Dongsheng; Zhang, Haibo; Zhang, HongMei; Zhang, Li; Zhang, Longfeng; Zhang, Qiuyu; Zhang, Tongmei; Zhang, Bicheng; Zhao, Jun; Zhao, Mingfang; Zheng, Xiaobin; Zhong, Qiaofeng; Zhou, Jin; Zhou, Penghui; Zhu, Zhengfei; Zou, Juntao; Zou, Zihua

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

安罗替尼联合埃克替尼作为EGFR突变合并其他突变的晚期非鳞状非小细胞肺癌的潜在治疗方案:前瞻性II期多中心ALTER-L004研究的最终分析

Zhang, Linlin; Wang, Liuchun; Wang, Jingya; Chen, Jinliang; Meng, Zhaoting; Liu, Zhujun; Jiang, Xiangli; Wang, Xinyue; Huang, Chun; Chen, Peng; Liang, Yan; Jiang, Richeng; Wang, Jing; Zhong, Diansheng; Shang, Yanhong; Zhang, Yan; Zhang, Cuiying; Huang, Dingzhi

A novel pyroptosis-related prognostic signature for lung adenocarcinoma: Identification and multi-angle verification

一种新型的与细胞焦亡相关的肺腺癌预后特征:鉴定和多角度验证

Wang, Xinyue; Zhou, Jing; Li, Zhaona; Chen, Xiuqiong; Wei, Qianhui; Chen, Kaidi; Jiang, Richeng

Investigation and verification of GIMAP6 as a robust biomarker for prognosis and tumor immunity in lung adenocarcinoma

研究和验证GIMAP6作为肺腺癌预后和肿瘤免疫的可靠生物标志物

Chen, Xiuqiong; Li, Zhaona; Wang, Xinyue; Zhou, Jing; Wei, Qianhui; Chen, Kaidi; Jiang, Richeng